Stuart Walter Peltz, Chief Executive Officer at PTC THERAPEUTICS, INC. (PTCT), sold 571,436 shares at $61.43 ($35.3M) on 2020-12-30, disclosed to the SEC on 2020-12-31.
Open-market sale of $35.3M PTCT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.43 | 77,939 | $4.8M | 13.6% |
| 2 | $61.43 | 122,790 | $7.5M | 21.4% |
| 3 | $61.43 | 122,790 | $7.5M | 21.4% |
| 4 | $61.43 | 77,939 | $4.8M | 13.6% |
| 5 | $62.27 | 30,060 | $1.9M | 5.3% |
| 6 | $62.27 | 30,060 |
| $1.9M |
| 5.3% |
| 7 | $62.34 | 38,779 | $2.4M | 6.9% |
| 8 | $62.34 | 38,779 | $2.4M | 6.9% |
| 9 | $63.19 | 8,212 | $519K | 1.5% |
| 10 | $63.19 | 8,212 | $519K | 1.5% |
| 11 | $63.25 | 7,938 | $502K | 1.4% |
| 12 | $63.25 | 7,938 | $502K | 1.4% |
| Total | $61.74 avg | 571,436 | $35.3M | 100% |
| Filing → |
| PTCT | SELL | 2023-01-12 | $257K | — | Filing → |
| PTCT | SELL | 2023-01-11 | $160K | — | Filing → |
| PTCT | SELL | 2022-06-09 | $11K | — | Filing → |